| Breast Cancer |
1 |
1 |
| Biologic Therapy |
0 |
0.9 |
| Triple Negative Breast Cancer |
0 |
0.8 |
| HER2-Positive Breast Cancer |
0 |
0.8 |
| Cancer |
0 |
0.8 |
| Antineoplastic Drug |
0 |
0.6 |
| Targeted Cancer Therapy |
0 |
0.6 |
| Antibody Drug Conjugates |
0 |
0.56 |
| Hodgkin Lymphoma |
0 |
0.56 |
| Metastasis |
0 |
0.48 |
| Breast |
0 |
0.45 |
| Genomic Medicine |
0 |
0.41 |
| Chemotherapy |
0 |
0.39 |
| Humanized Monoclonal Antibody |
0 |
0.17 |
| Antigens |
0 |
0.11 |
| Clinical Research |
0 |
0.06 |
| Genetics |
0 |
0.06 |
| Healthcare and Medical Technology |
0 |
0.06 |
| Surgery |
0 |
0.06 |